Allakos Inc. (ALLK)
NASDAQ: ALLK · Real-Time Price · USD
0.3265
-0.0001 (-0.03%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Allakos Employees
Allakos had 131 employees as of December 31, 2023. The number of employees increased by 8 or 6.50% compared to the previous year.
Employees
131
Change (1Y)
8
Growth (1Y)
6.50%
Revenue / Employee
n/a
Profits / Employee
-$884,107
Market Cap
29.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ALLK News
- 24 days ago - Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share - GlobeNewsWire
- 6 weeks ago - Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Lycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reveals Immunology Pipeline - GlobeNewsWire
- 2 months ago - Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm - GlobeNewsWire
- 3 months ago - Why Is Allakos Stock Plunging On Monday? - Benzinga
- 3 months ago - Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring - GlobeNewsWire
- 6 months ago - Allakos Runs Up Into A Near-Term Catalyst - Seeking Alpha
- 6 months ago - Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire